SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses

Cited by (172)

Items 101–172 of 172

1. Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant
   Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Tengchuan Jin · 2022 · Infection and Drug Resistance
2. HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2
   Ludmila N. Bubnova, Irina E. Pavlova, Maria Terentieva, Glazanova Tv, Elena Belyaeva, Sergei Sidorkevich, N. S. Bashketova, Irina Chkhingeria, Malvina A. Kozhemyakina, Азаров Даниил Валерьевич et al. · 2022 · International Journal of Environmental Research and Public Health
3. A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides
   Tamar Ratishvili, Huy Quang Quach, Iana H. Haralambieva, Yogesh R. Suryawanshi, Inna G. Ovsyannikova, Richard B. Kennedy, Gregory A. Poland · 2023 · Vaccine
4. Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV
   José L. Casado, Pilar Vizcarra, Sara Martín-Colmenarejo, Judith del Pino, Sandra Gómez-Maldonado, Adrián Martín-Hondarza, Alejandro Vallejo · 2023 · AIDS
5. Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies
   Dilip Thomas, Phillip Chung-Ming Yang, Joseph C. Wu, Nazish Sayed · 2025 · Journal of Molecular and Cellular Cardiology
6. T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects
   Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, Irene Ruspantini, Donatella R. M. Negri, Martina Borghi, Maria Laura De Angelis, Francesca Luciani, Antonio Martina, Silvia Taglieri et al. · 2024 · Biomolecules
7. The molecular mechanisms of CD8+ T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions
   Shasha Deng, Zhihao Xu, Jing Hu, Yunru Yang, Fang Zhu, Zhuan Liu, Hongliang Zhang, Songquan Wu, Tengchuan Jin · 2024 · Frontiers in Immunology
8. A high-throughput immunopeptidome platform for MHC II alleles to characterize antigen-specific CD4+ T cells
   Jing Chen, Xu Zhu, Jun Huo, Shang Wu, Ting Zhou, Chunyu Cheng, Hao Dong, Yan Li, Xianchi Dong, Yuxin Chen · 2025 · Biomedical Technology
9. The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
   Eduardo Tosta · 2021 · Exploration of Immunology
10. COVID-19 Pandemic: Escape of Pathogenic Variants and MHC Evolution
    Pierre Pontarotti, Julien Paganini · 2022 · International Journal of Molecular Sciences
11. Immunology and controlling of coronaviruses; the current enemy for humanity: A review
    Sarah I. Othman, Mohamed A. Nayel, Maha Abdulla Alwaele, Haifa E. Alfassam, Gasem Mohammad Abu-Taweel, Naif Ghazi Altoom, Ahmed M. Almalki, Ahmed A. Allam, Asma M. Alturki, Rehan M. El-Shabasy · 2021 · International Journal of Biological Macromolecules
12. Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
    Nina Le Bert, Anthony Tanoto Tan, Kamini Kunasegaran, Adeline Chia, Nicole Tan, Qi Chen, Shou Kit Hang, Martin Qui, Bianca Su-Wan Chan, Jenny Guek Hong Low et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
13. Resistance potential of the HLA-A2-restricted immunodominant SARS-CoV-2-specific CD8+ T cell receptor repertoire to antigenic drift
    Michael J. Malone, Chao Ming Huang, Yong Zhang, Yijun Qi, Lea Williams, Laura F. Su, Jizhong Lou, Ning Jenny Jiang · 2025 · Nature Communications
14. CoV2-TCR: A web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes
    Xingxing Jian, Yu Long Zhang, Jingjing Zhao, Zhuoming Zhao, Manman Lu, Lu Xie · 2023 · Computational and Structural Biotechnology Journal
15. Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?
    Arup Acharjee, Joshua Stephen Kingsly, Madhura Kamat, Vishakha Kurlawala, Aparajita Chakraborty, Priyanka A. Vyas, Radhika A. Vaishnav, Sanjeeva Srivastava · 2022 · Espert Review of Proteomics
16. Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
    Eduardo Cheuiche Antonio, Mariana Rost Meireles, Marcelo Alves de Souza Bragatte, Gustavo Fioravanti Vieira · 2022 · Frontiers in Immunology
17. Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
    Gabriel Duette, Eunok Lee, Gabriela Martins Costa Gomes, Katie Tungatt, Chloe M. Doyle, Vicki V Stylianou, Ashley Lee, Susan Maddocks, Janette Taylor, Rajiv Khanna et al. · 2023 · ImmunoHorizons
18. Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1–BA.5 Peptides by HLA Molecules
    Stepan A. Nersisyan, M. Yu. Shkurnikov, Anton Zhiyanov, Victor Novosad, Alexander Tonevitsky · 2022 · Doklady Biochemistry and Biophysics
19. Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry
    Ke Pan, Yulun Chiu, Eric L. Huang, Michelle M. Chen, Junmei Wang, Ivy P. Lai, Shailbala Singh, Rebecca Shaw, Michael J. MacCoss, Cassian Yee · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
20. Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes
    Ksenia V. Zornikova, Dmitry Vladimirovich Dianov, N. O. Ivanova, Vassa D Davydova, Tatiana A. Nenasheva, Ekaterina I. Fefelova, Боголюбова Аполлинария Васильевна · 2024 · International Journal of Molecular Sciences
21. Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity
    David M. Florian, Michael W Bauer, Amelie Popovitsch, Ingrid Faé, David Niklas Springer, Marianne Graninger, Marianna Theresia Traugott, Lukas Weseslindtner, Stephan Walter Aberle, Gottfried Fischer et al. · 2025 · Frontiers in Immunology
22. Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development
    Huixiong Deng, Yanlei Li, Gefei Wang, Rui Li · 2025 · Biology
23. CHARM: COVID-19 Health Action Response for Marines–Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test
    Martha Sedegah, Chad K. Porter, Michael R. Hollingdale, Harini D. Ganeshan, Jun Huang, Carl W. Goforth, María Belmonte, Arnel D. Belmonte, Dawn L. Weir, Rhonda A. Lizewski et al. · 2022 · PLoS ONE
24. Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike
    Kamil Wnuk, Jeremi Sudol, Patricia Spilman, Patrick Soon‐Shiong · 2022 · Frontiers in Immunology
25. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition
    Thandeka Nkosi, Caroline Chasara, Anele Mbatha, Mza Nsimbi, Andrea Olga Papadopoulos, Tiza L Nguni, Farina Karim, Mohomed Yunus S Moosa, Inbal Gazy, Kondwani Jambo et al. · 2022 · medRxiv
26. SABRE: Self-Attention Based model for predicting T-cell Receptor Epitope Specificity
    Zicheng Wang, Yufeng Shen · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
27. Methodological approach to identify immunogenic epitopes candidates for vaccines against emerging pathogens tailored to defined HLA populations
    Nicolás Lalinde-Ruiz, Laura Camila Martínez-Enriquez, Daniel Alzate Gutierrez, Holman Hernandez Nieto, Luís Fernando Niño, Carlos Parra-López · 2025 · Computational Biology and Chemistry
28. The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis
    Lin Yuan, Madison Stoddard, Sharanya Sarkar, Debra Van Egeren, Shruthi Mangalaganesh, Ryan P. Nolan, Michael S. Rogers, Greg Hather, Laura Forsberg White, Arijit Chakravarty · 2025 · Vaccines
29. Characterization of human CMV-specific CD8+ T cells using multi-layer single-cell omics
    Ioanna D. Gemünd, Lorenzo Bonaguro, Matthias Becker, Sophie Merit Müller, Clemens Joos, Elena De Domenico, Anna C. Aschenbrenner, Joachim Ludwig Schultze, Andreas Moosmann, Marc Beyer · 2025 · Cell Reports Methods
30. In Silico Analysis of Post-COVID-19 Condition (PCC) Associated SNP rs9367106 Predicts the Molecular Basis of Abnormalities in the Lungs and Brain Functions
    Amit K. Maiti · 2025 · International Journal of Molecular Sciences
31. Computational Design of Next‐Generation Universal Nanovaccine for COVID ‐19: A Self‐Assembling Coiled‐Coil Platform Approach
    Puja Jaishwal, Satarudra Prakash Singh · 2026 · Peptide Science
32. De novo design of anti-variant COVID-19 vaccine
    Goswami, Arpita, Kumar, Madan, Ullah, Samee, Gore, Milind M · 2023 · Biology Methods and Protocols
33. In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants
    Shivangi Sharma, Diya Roy, Sarah Cherian · 2024 · Scientific Reports
34. Extensive cross-reactive T cell epitopes across SARS-CoV-2 Omicron variant spikes with finite immune evasion mutations
    Mengze Gan, Jinge Cao, Qi Ouyang, Xinyue Xu, Xingxing Wang, Peihang Dan, Yinlong Yao, Hui Fu, Xuanyu Yao, Xiaosong Lin et al. · 2025 · Journal of Translational Medicine
35. Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus
    Mark Smyth, Kseniya Khamina, Alexandra Popa, Venugopal Gudipati, Benedikt Agerer, Alexander Lercher, Lindsay Kosack, Lukas Endler, Hatoon Baazim, Csilla Viczenczová et al. · 2021 · Frontiers in Immunology
36. Beyond Spike: Identification of nine highly prevalent SARS-CoV-2-specific CD8 T-cell epitopes in a large Norwegian cohort
    Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, Marina Delić-Šarac, Trung The Tran, Cathrine F. Knetter, Ke‐Zheng Dai, Torfinn Støve Madssen, John Torgils Vaage, Alice Gustavsen et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
37. Impact of mutations in immunodominant regions of SARS-CoV-2 variants on recognition by CD8+ T cell: An in silico analysis
    Greice Carolina Santos da Silva, Victoria Cruz Paraná, Filipe Ferreira de Almeida Rego, Manuel Portela, Mariana Barros Queiroz, Raimundo Coutinho, Carlos Gustavo Régis da Silva, Luana Leandro Gois, Maria Fernanda Rios Grassi · 2025 · Journal of Infection and Public Health
38. C > U mutations generate immunogenic peptides in SARS-CoV-2
    Gergő Mihály Balogh, Balázs Koncz, Leó Asztalos, Eszter EA Ari, Nikolett Gémes, Gábor J. Szebeni, Benjamin Tamás Papp, Flóra Tóth, Balázs Papp, Csaba Pál et al. · 2025 · Nature Communications
39. Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination
    Daryl Geers, Muriel Aguilar-Bretones, Luca M. Zaeck, Paul A. Gill, Cristina Gonzalez‐Lopez, Kim Handrejk, Ngoc H. Tan, Yvette den Hartog, Lennert Gommers, Susanne Bogers et al. · 2026 · Journal of Infection
40. Preclinical evaluation of DENV1 mRNA vaccines in mice: Toward improved neutralizing antibody and T cell responses
    Chirayus Khawsang, Eakachai Prompetchara, Supichcha Saithong, Kittipan Tharakhet, Papatsara Kaewpang, Nongnaphat Yostrerat, Pachara Wangsoontorn, Patrawadee Pitakpolrat, Supranee Buranapraditkun, Chunya Puttikhunt et al. · 2026 · Biomedicine & Pharmacotherapy
41. SARS-CoV-2 Infection and Vaccination, Immune Dysregulation, and Cancer
    Dace Pjanova, Aysha Rafeeque · 2026 · Vaccines
42. HLA class I escape drives the evolution of SARS-CoV-2 in human populations
    Ekaterina D. Riumina, Evgeniia I. Alekseeva, Galya V. Klink, Stepan E Feigin, Iaroslava Vinogradova, Natalia Ivanova, Dmitry Dianov, Ksenia V. Zornikova, Vassa D Davydova, Боголюбова Аполлинария Васильевна et al. · 2026 · Proceedings of the National Academy of Sciences
43. Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
    Sevgi Kalkanlı Taş, Merve Saide Uzunoğlu, Aylin Seher Uzunoğlu, Duygu Kırkık, Derya Altunkanat, Nevin Kalkanli · 2022 · TURKISH JOURNAL OF BIOLOGY
44. Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice
    Kanwal Khalid, Hui Xuan Lim, Ayaz Anwar, Soon Hao Tan, Jung Shan Hwang, Seng‐Kai Ong, Chit Laa Poh · 2024 · AAPS PharmSciTech
45. A nonadjuvanted HLA-restricted peptide vaccine induced both T and B cell immunity against SARS-CoV-2 spike protein
    Yi-Ru Lee, Chiung-Wen Liou, I‐Hua Liu, Jia-Ming Chang · 2024 · Scientific Reports
46. Omicron Variant Could Be an Antigenic Shift of SARS-CoV-2
    Anju Kaushal · 2025 · COVID
47. Adenosine-related small molecules show utility of recall antigen assay to screen compounds for off-target effects on memory T cells
    Eden Kleiman, Gloria Sierra, Binchen Mao, Dennie Magcase, Marybeth George, Pirouz M. Daftarian · 2021 · Scientific Reports
48. SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
    Zhihua Fan, Shixin Duan, Fangfen Liu, Wei Shi, Ziye Yang, Ruiyang Bai, Tao Li, Jingxian Chen, Hongfu Xie, Ji Li et al. · 2022 · Frontiers in Immunology
49. In Silico Defined SARS-CoV2 Epitopes May Not Predict Immunogenicity to COVID19
    Ke Pan, Yulun Chiu, Michelle M. Chen, Junmei Wang, Ivy P. Lai, Shailbala Singh, Rebecca Shaw, Cassian Yee · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
50. Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
    Sevgi Kalkanlı Taş, Merve Saide Uzunoğlu, Aylin Seher Uzunoğlu, Duygu Kırkık, Derya Altunkanat, Nevin Kalkanli · 2021 · TURKISH JOURNAL OF BIOLOGY
51. Clonal diversity determines persistence of SARS-CoV-2 epitope-specific T cell response
    Ksenia V. Zornikova, Alexandra A. Khmelevskaya, Savely A. Sheetikov, Dmitry Olegovych Kiryukhin, Olga V. Shcherbakova, Aleksei Titov, Ivan V. Zvyagin, Grigory Aleksandrovich Efimov · 2022 · medRxiv
52. T cell immunity of the nonadjuvanted HLA-restricted peptide COVID-19 vaccine
    Yi-Ru Lee, Chiung-Wen Liou, I‐Hua Liu, Jia-Ming Chang · 2023 · Research Square
53. The Omicron Strain of the SARS-CoV-2 Coronavirus and Its Variants
    S. G. Sсherbak, D. A. Vologzhanin, A. Golota, A. Sarana, S. Makarenko · 2023 · Journal of Clinical Practice
54. Understanding SARS-CoV-2 spike glycoprotein clusters and their impact on immunity of the population from Rio Grande do Norte, Brazil
    Diego Gomes Teixeira, João Firmino Rodrigues-Neto, Dayse Caroline Severiano da Cunha, Selma M. B. Jerônimo · 2024 · Infection Genetics and Evolution
55. Evolution of SARS-COV-2
    Manuela Sironi, Fernando Gónzález‐Candelas · 2024 · Elsevier eBooks
56. Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
    Antonio Bertoletti, Martin Qui, Joey Ming Er Lim · 2025 · Elsevier eBooks
57. Introducing immunology: Types of immunity, immune responses, deficiencies, and disorders
    Zainab N. Rahman, Faheem Shehjar, Reetika Mahajan · 2025 · Elsevier eBooks
58. Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes
    Aljawharah Alrubayyi, Hsinyen Huang, Gaurav D. Gaiha · 2025 · Infectious Disease Clinics of North America
59. Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region
    N. Ngandu, B. Fielding, P. van Heusden, Kuhle Mcinga, Kriheska Francis, G. Harkins · 2025 · PLoS Comput. Biol.
60. Effects of aging and inflammation on antigen-specific CD8+ T-cell responses that protect against severe disease following SARS-CoV-2 infection
    Takuto Nogimori, Takuya Yamamoto · 2025 · Uirusu
61. TinyHLAnet : A Light‐Weight 3D Structure‐Aware Architecture for Rapid and Explainable Identification of CD8 + T‐Cell Antigens
    Naren Chandran Sakthivel, Sumanta Mukherjee, Nagasuma R Chandra · 2025 · HLA
62. Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination
    Daryl Geers, Muriel Aguilar-Bretones, Luca M. Zaeck, Paul A. Gill, Cristina Gonzalez‐Lopez, Kim Handrejk, Ngoc H. Tan, Yvette den Hartog, Lennert Gommers, Susanne Bogers et al. · 2025 · medRxiv
63. Impaired and restored CD8+ T cell responses to a sequentially mutated spike epitope in Omicron variants
    Eun Joo Chung, Soyoung Park, Su‐Hwan Kim, Ju‐Yeon Choi, Hye-Sook Jeong, Jae‐Hoon Ko, Joon Young Song, Young Jae Lee · 2025 · Frontiers in Immunology
64. HLA-C–derived peptide MH-1 as an early-stage intervention against SARS-CoV-2 infection
    Ting-Yan Jian, S. T. Huang, Chia-Yu Chang, Chih-Heng Huang, Lik Voon Kiew, Yu-Ling Lin, Y. -H. Liu, Yen-Chin Liu, Yen-Chen Chen, Yi-Xuan Huang et al. · 2026 · Molecular Medicine
65. Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice
    Vladimir A. Gushchin, Andrei E. Siniavin, Andrei A. Pochtovyi, Alina Sh. Dzharullaeva, Д. Н. Щербинин, Anastasiya S. Ungur, Тухватулин Амир Ильдарович, Inna V. Shuliakova, Denis A. Kleymenov, Elena P. Mazunina et al. · 2026 · Vaccines
66. T cell decision-making decodes the dynamic antigenic landscape
    Inbal Eizenberg-Magar, Lior Dayan, Benny Chain, Yaron E. Antebi · 2026 · Frontiers in Immunology
67. Host-pathogen interplay of Orientia tsutsugamushi: pathomolecular epidemiology and phylo-immuno profiling in naturally infected rodents and shrews
    Akash Balasaheb Mote, Himani Dhanze, Asok Kumar Mariappan, Prasad Thomas, Princee Verma, Vibha Singh, Rahul Singh, Ishita Gupta, Murthy Suman Kumar, Rajeev Singh et al. · 2026 · Microbial Pathogenesis
68. Antigenic Variation and Immune Recognition Inference From the COVID‐19 Pandemic: An In Silico Comparative Analysis of Spike T Cell Epitopes From the SARS‐CoV‐2 Variants of Concern
    Katherine Li, Sandstrom Pv, Hezhao Ji · 2026 · Influenza and Other Respiratory Viruses
69. Functional Pairing of TCR-peptide-MHC Interactomes by Single-cell Clonal Expansion
    Liu Daisy Liu, Seung Won Shin, Kevin M. Joslin, Chunyu Wang, James Pai, Rong Ma, Xinyu Xiang, Iain C. Clark, K. Christopher García · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
70. Understanding HLA risk in immune-mediated inflammatory diseases requires antigen discovery
    Hesham ElAbd, Aya K.H. Mahdy, André Franke · 2026 · Trends in Immunology
71. Smallpox vaccine elicits CD8 + T cell immunity persisting over four decades with cross-recognition of monkeypox virus
    Yujuan Du, zongmian yang, Yinying Xiao, Huajun Duan, Hong Kong, Chanchan Xiao, Jun Su · 2026 · Aging Research
72. Host Genetic Determinants of SARS-CoV-2 Susceptibility in Transplant Recipients and Donor Candidates: A Multicohort Analysis of HLA Variation
    Makbule Nihan Somuncu, Mahmut Selman Yıldırım, Ayşe Gül Zamanı, Zahide Aleyna Yılık, Sümeyye Sultan Var · 2026 · Biomedicines